Literature DB >> 24899799

Optical coherence tomographic findings at the fixation point in a case of bilateral congenital macular coloboma.

Kosuke Abe1, Jumi Shirane2, Masuo Sakamoto3, Fumi Tanabe3, Kazuki Kuniyoshi3, Chota Matsumoto3, Yoshikazu Shimomura3.   

Abstract

BACKGROUND: Congenital macular coloboma is a rare ocular disease that consists of atrophic lesions in the macula with well-circumscribed borders. We report the findings of spectral domain optical coherence tomography (SD-OCT) at the fixation point in a case of bilateral macular coloboma. CASE REPORT: The subject is a 4-year-old boy. He visited our hospital at age 1 year and 4 months for the evaluation of strabismus. The fundus examination of both eyes showed round-shaped sharply-demarcated atrophic lesions involving the macula with large choroidal vessels and bared sclera at the base. Immunologic tests including toxoplasmosis, rubella, varicella, herpes virus, and human T-cell leukemia virus were all negative. At age 4 years and 1 month, cycloplegic refraction showed insignificant refractive errors and his best corrected visual acuity was 0.6 bilaterally. The SD-OCT showed a crater-like depression accompanying atrophic neurosensory retina, and the absence of retinal pigment epithelium and choroid. Examination of the fixation behavior by visuscope showed steady fixation with an area 0.5° nasal to the nasal edge of the atrophic lesion bilaterally. The SD-OCT findings at fixation area showed remaining normal retinal structures involving inner segment-outer segment (IS/OS) junction line.
CONCLUSION: The findings of SD-OCT have been shown to be useful in the diagnosis of macular coloboma. In the fixation point, the structure of retina and choroid were well preserved.

Entities:  

Keywords:  macular structure; pediatric macular disease; strabismus

Year:  2014        PMID: 24899799      PMCID: PMC4039399          DOI: 10.2147/OPTH.S63593

Source DB:  PubMed          Journal:  Clin Ophthalmol        ISSN: 1177-5467


Introduction

Congenital macular coloboma appears as atrophic lesions with well-circumscribed borders unilaterally or bilaterally, which result in a nonprogressive decrease in visual acuity. These findings are also seen in patients with intrauterine infection, especially toxoplasmosis. Spectral domain (SD) optical coherence tomography (OCT) is a beneficial tool to make a diagnosis of macular coloboma. We report on the SD-OCT findings in a patient with bilateral macular coloboma. Furthermore, we show the retinal structures at the fixation point.

Case report

The subject was a 4-year-old boy. He visited our hospital at age 1 year and 4 months for the evaluation of strabismus. He had medical history of ventricular septal defect. The anterior segments were normal. The Hirschberg test revealed an exotropia of 10°. The fundus examination of both eyes showed round-shaped sharply-demarcated atrophic lesions involving the macula with large choroidal vessels and the bared sclera at the base (Figure 1). The atrophic lesion was approximately 1 disc diameter (DD) in height and 1.2 DD in width in the right eye, and 1.2 DD in height and 1.5 DD in width in the left eye. Some retinal vessels were disturbed at the margin. Immunologic tests including toxoplasmosis, rubella, varicella, herpes virus, and human T-cell leukemia virus were all negative. Anti-toxoplasma antibody was also negative in his mother. At age 4 year and 1 month, cycloplegic refraction showed insignificant refractive errors and his best corrected visual acuity was 0.6 bilaterally. No stereoacuity was detected with TNO stereo test and Titmus Stereo Test. The fundus examination showed no significant changes except for some pigmentation in the atrophic lesions (Figure 2). Examination of fixation behavior by visuscope showed steady fixation in the normal area close to the nasal edge of the atrophic lesion bilaterally (Figure 2). The SD-OCT (Cirrus HD-OCT; Carl Zeiss Meditec AG, Jena, Germany) showed a crater-like depression accompanying atrophic neurosensory retina, and the absence of the retinal pigment epithelium and choroid (Figure 3). The retinal structures of the fixation area were normal involving IS/OS junction line (Figure 3). In addition, it was not difficult to get the SD-OCT images on him with dilated pupil and without any anesthesia. At age 5 years and 3 months, his best corrected visual acuity was 1.0 OD and 0.8 OS.
Figure 1

Fundus photographs taken at age 1 year and 4 months.

Notes: (A) Right eye. (B) Left eye.

Figure 2

Fundus photographs taken at age 4 years and 1 month.

Notes: (A) Right eye. (B) Left eye. The white crosses show the fixation points.

Figure 3

SD-OCT images at age 4 years and 1 month.

Notes: (A) Right eye. (B) Left eye. (A and B) ILM-RPE map on the macular cube 200×200. Cross points of vertical and horizontal lines show fixation points (white crosses). (C) B-scans. The bars show the fixation points (white arrows).

Abbreviations: ILM-RPE, internal limiting membrane – retinal pigment epithelium; SD-OCT, spectral domain optical coherence tomography.

Discussion

Congenital macular coloboma is thought to result from incomplete differentiation of the arcuate bundles along the horizontal raphe during development.1 However, its morphology of the macular lesion is very similar to that of postinflammatory congenital macular scars resulting from ocular toxoplasmosis. Differentiation between macular coloboma and postinflammatory scarring is important to decide the course of treatment. SD-OCT is a beneficial tool in making a differential diagnosis of macular degeneration.2 The OCT findings of this case showed absence of the retina and choroid. This structure conformed well to the findings of previous reports.2–5 On the other hand, the OCT features of congenital toxoplasmosis macular scars are retinal thinning, retinal pigment epithelium hyper-reflectivity, excavation, intraretinal cysts, and fibrosis.6,7 Added to the results of immunologic test, the OCT findings showed that the diagnosis of this patient was congenital macular coloboma. The fixation points of the patient were located close to the nasal edge of the atrophic lesion. The OCT findings suggested that the retinal structures of the fixation points were well conserved involving IS/OS junction line. It was thought that the patient made adaptation to reflect the image on the comparatively healthy peripheral retina. This phenomenon is known as eccentric viewing.8,9 There have been no reports on the structure of the fixation point, although the retinal structure of the fixation point influences the visual acuity and binocularity of patients. The visual acuity from previous reports1–4,10–12 ranged from light perception to 0.8. However, the atrophic lesions of this case were comparatively smaller than other cases and the conserved normal retinal structures near the fovea resulted in the patient having better visual acuity than those of other cases, although he had exotropia and no stereoacuity. When his dominant eye perceived an image on the fixation point, the fellow eye perceived the image on the atrophic lesion, but the image on the atrophic lesion did not reach the visual cortex. This suggests that his monofixation is not caused by suppression.

Conclusion

The SD-OCT imaging is helpful in making a diagnosis and determining the course of treatments. Furthermore, the structure of the fixation point has a critical influence on the visual acuity and prognosis of congenital macular coloboma.
  12 in total

1.  Phenomenology of eccentric fixation.

Authors:  G K VON NOORDEN; G MACKENSEN
Journal:  Am J Ophthalmol       Date:  1962-04       Impact factor: 5.258

2.  Optical coherence tomographic features of unilateral macular coloboma.

Authors:  Nazimul Hussain; L S Mohan Ram
Journal:  Indian J Ophthalmol       Date:  2007 Jul-Aug       Impact factor: 1.848

3.  The Westheimer function as an indicator of fixation locus.

Authors:  J M Enoch; C A Johnson
Journal:  Am J Ophthalmol       Date:  1977-04       Impact factor: 5.258

4.  Intraoperative OCT of bilateral macular coloboma in a child with Down syndrome.

Authors:  Hassan A Aziz; Marco Ruggeri; Audina M Berrocal
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2011-07-19       Impact factor: 1.402

5.  Congenital macular coloboma in Down syndrome.

Authors:  K Yamaguchi; M Tamai
Journal:  Ann Ophthalmol       Date:  1990-06

6.  Optical coherence tomographic finding in a case of macular coloboma.

Authors:  Joo Youn Oh; Young Suk Yu; Jeong-Min Hwang; Kyu Hyung Park
Journal:  Korean J Ophthalmol       Date:  2007-09

Review 7.  The characteristic features of optical coherence tomography in posterior uveitis.

Authors:  M J Gallagher; T Yilmaz; R A Cervantes-Castañeda; C S Foster
Journal:  Br J Ophthalmol       Date:  2007-06-25       Impact factor: 4.638

8.  Imaging of congenital toxoplasmosis macular scars with optical coherence tomography.

Authors:  Seema Garg; Marilyn B Mets; Srilaxmi Bearelly; Rebecca Mets
Journal:  Retina       Date:  2009-05       Impact factor: 4.256

9.  Bilateral macular coloboma and pigmented paravenous retinochoroidal atrophy.

Authors:  M S Chen; C H Yang; J S Huang
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

10.  Dominant macular colobomata.

Authors:  J Satorre; J M López; J Martinez; P Piñera
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1990 May-Jun       Impact factor: 1.402

View more
  2 in total

Review 1.  Ocular coloboma-a comprehensive review for the clinician.

Authors:  Gopal Lingam; Alok C Sen; Vijaya Lingam; Muna Bhende; Tapas Ranjan Padhi; Su Xinyi
Journal:  Eye (Lond)       Date:  2021-03-21       Impact factor: 3.775

2.  A Brazilian report using serological and molecular diagnosis to monitoring acute ocular toxoplasmosis.

Authors:  Mariana Previato; Fábio Batista Frederico; Fernando Henrique Antunes Murata; Rubens Camargo Siqueira; Amanda Pires Barbosa; Aparecida Perpétuo Silveira-Carvalho; Cristina da Silva Meira; Vera Lúcia Pereira-Chioccola; Ricardo Gava; Plínio Pereira Martins Neto; Luiz Carlos de Mattos; Cinara Cássia Brandão de Mattos
Journal:  BMC Res Notes       Date:  2015-12-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.